These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9537591

  • 41. Peripheral blood lymphocytes from psoriatic patients are hyporesponsive to beta-streptococcal superantigens.
    Horiuchi N, Aiba S, Ozawa H, Sugawara S, Rikiishi H, Kumagai K, Tagami H.
    Br J Dermatol; 1998 Feb; 138(2):229-35. PubMed ID: 9602866
    [Abstract] [Full Text] [Related]

  • 42. Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
    Tordsson JM, Ohlsson LG, Abrahmsén LB, Karlström PJ, Lando PA, Brodin TN.
    Cancer Immunol Immunother; 2000 Mar; 48(12):691-702. PubMed ID: 10752477
    [Abstract] [Full Text] [Related]

  • 43. In vitro and in vivo T cell oligoclonality following chronic stimulation with staphylococcal superantigens.
    Kim KS, Jacob N, Stohl W.
    Clin Immunol; 2003 Sep; 108(3):182-9. PubMed ID: 14499241
    [Abstract] [Full Text] [Related]

  • 44. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.
    Giantonio BJ, Alpaugh RK, Schultz J, McAleer C, Newton DW, Shannon B, Guedez Y, Kotb M, Vitek L, Persson R, Gunnarsson PO, Kalland T, Dohlsten M, Persson B, Weiner LM.
    J Clin Oncol; 1997 May; 15(5):1994-2007. PubMed ID: 9164211
    [Abstract] [Full Text] [Related]

  • 45. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T, Harada M, Tamada K, Abe K, Nomoto K.
    Anticancer Res; 1997 May; 17(6D):4259-68. PubMed ID: 9494518
    [Abstract] [Full Text] [Related]

  • 46. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.
    Dohlsten M, Abrahmsén L, Björk P, Lando PA, Hedlund G, Forsberg G, Brodin T, Gascoigne NR, Förberg C, Lind P.
    Proc Natl Acad Sci U S A; 1994 Sep 13; 91(19):8945-9. PubMed ID: 8090750
    [Abstract] [Full Text] [Related]

  • 47. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI, Baecher-Steppan L, Shepherd DM, Oughton JA, Vorderstrasse BA, DeKrey GK.
    J Immunol; 1996 Sep 15; 157(6):2310-9. PubMed ID: 8805628
    [Abstract] [Full Text] [Related]

  • 48. Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer.
    Liu T, Li L, Yin L, Yu H, Jing H, Liu Y, Kong C, Xu M.
    Biosci Biotechnol Biochem; 2017 Sep 15; 81(9):1741-1746. PubMed ID: 28715277
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.
    Riesbeck K, Billström A, Tordsson J, Brodin T, Kristensson K, Dohlsten M.
    Clin Diagn Lab Immunol; 1998 Sep 15; 5(5):675-82. PubMed ID: 9729535
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Superantigen-induced lysis of melanoma cells.
    Krull F, Holzer U, Ihle J, Bethge W, Fierlbeck G, Kalland T, Dohlsten M, Niethammer D, Dannecker GE.
    Melanoma Res; 1997 Jun 15; 7(3):214-22. PubMed ID: 9195560
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein.
    Ma W, Yu H, Wang Q, Bao J, Yan J, Jin H.
    Cancer Immunol Immunother; 2004 Feb 15; 53(2):118-24. PubMed ID: 14574492
    [Abstract] [Full Text] [Related]

  • 55. Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies.
    Alpaugh RK, Schultz J, McAleer C, Giantonio BJ, Persson R, Burnite M, Nielsen SE, Vitek L, Persson B, Weiner LM.
    Clin Cancer Res; 1998 Aug 15; 4(8):1903-14. PubMed ID: 9717818
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma.
    Cauley LS, Miller EE, Yen M, Swain SL.
    J Immunol; 2000 Dec 01; 165(11):6056-66. PubMed ID: 11086037
    [Abstract] [Full Text] [Related]

  • 58. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S, Seelig M, Lee HM, Lin J.
    J Immunol; 1995 Jul 15; 155(2):609-18. PubMed ID: 7608539
    [Abstract] [Full Text] [Related]

  • 59. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells.
    Coppola MA, Blackman MA.
    Int Immunol; 1997 Sep 15; 9(9):1393-403. PubMed ID: 9310843
    [Abstract] [Full Text] [Related]

  • 60. Injury primes the immune system for an enhanced and lethal T-cell response against bacterial superantigen.
    Kell MR, Kavanaugh EG, Goebel A, Soberg CC, Lederer JA.
    Shock; 1999 Aug 15; 12(2):139-44. PubMed ID: 10446895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.